NLRP3 and COVID-19: Complementary balance, especially with respect to C3 and C5 as a therapeutic approach, should be considered in the treatment of COVID-19, as they are also associated with the activation of the NLRP3 inflammasome, which generates pyroptosis, triggering tissue inflammatory aggravation [11,14].